There has been a lot of talk about the benefits of TXA in major trauma with minor differences in outcomes. If you’re looking for a big treatment benefit for TXA, look no further than the very sexy nose bleeds. This is an easy and safe intervention that EMS can provide that makes a real difference in a growing number of patients. If you like what you hear, please give us a 5-star rating on Apple Podcasts and other premier podcast purveyors and tell your friends to subscribe.

Are you worried about what might happen in your jurisdiction if COVID breaks out in your nursing homes? You should be. Dr. Jarvis reviews a NEJM paper in this episode: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. Afterward, he’s joined by a special guest, Dr. Jason Pickett. Dr. Pickett is the deputy medical director for Austin-Travis County EMS, assistant local health authority for Austin Public Health, and the host of the EMS podcast with the longest name ever. As always, please subscribe and give us a 5-star rating on Apple Podcasts. We’d love to hear your thoughts, questions, and suggestions. Join us on Twitter: @DrJeffJarvis, @EMSLighthouse.

We are living in a COVID world. And I am a COVID doc. This is a special episode of the EMS Lighthouse Project Podcast. Since the Jarvis household is quarantined in our bunker in Central Texas, I brought the family together to discuss how such a short piece of RNA has changed our world. Oh, and we talk about the MMWR report from Singapore that, apparently, got the CDC to change its stance on the use of public face masks. If you like what you hear, please give us a 5-star rating on Apple Podcasts and other premier podcast purveyors and tell your friends to subscribe. Most importantly, stay safe out there. Thank you for stepping up and caring for others in these difficult times. We appreciate each one of you. I’ve never been prouder to be in EMS.

Remember our podcast about amiodarone and lidocaine improving survival from arrest when given IV but not IO? Wait! There’s more. Another paper dropped looking at the same thing but with epinephrine instead of anti-dysrhythmics. Does this paper show the same thing? Is there something to this IV superiority thing? Dr. Jarvis breaks this new paper down. As always, please subscribe and give us a 5-star rating on Apple Podcasts. We’d love to hear your thoughts, questions, and suggestions. Join us on Twitter: @DrJeffJarvis, @EMSLighthouse

Have you ever given adenosine to a patient in SVT? Yeah? Did they like it? I didn’t think so. You’ve probably also given up trying to use the Valsalva maneuver because it doesn’t work very often. Wouldn’t it be great if there were a way to make the Valsalva more effective and, perhaps, avoid kicking the patient in the chest with adenosine? Dr. Jarvis reviews a paper in this episode that may offer just this. If you like what you hear, please give us a 5-star rating on Apple Podcasts and other premier podcast purveyors and tell your friends to subscribe.

Remember Episode 12, where we reviewed a Houston paper on DSD that showed worse outcomes with DSD? At the end of that pod, I spoke about an ongoing RCT trial comparing DSD to standard therapy AND vector change defibrillation. Well, the pilot phase of that trial is over and has JUST been published. It has some surprising preliminary results. Join us and find out how that study is going. If you like what you hear, please give us a 5-star rating on Apple Podcasts and other premier podcast purveyors and tell your friends to subscribe.

The final part of our coverage of some of the research from NAEMSP2020 in San Diego. If you missed any of the first three episodes, download them and listen. They were great! In this episode, we wrap up the series with outstanding discussions. We discuss the epidemiology of pediatric trauma activations with San Antonio’s Dr. Craig Cooley and finish up with a discussion with Dr. Henry Wang. Dr. Wang talks to us through an oral abstract he presented here on a secondary analysis looking at the impact of FPS in the PART trial comparing ET and King LT in cardiac arrest. As a bonus, he talked us through the original PART trial, where he was the principal investigator. As always, we want to hear your feedback. Let us know what you think: @DrJeffJarvis and @EMSLigthouse. Subscribe and give us an excellent rating on Apple Podcast.

And…we are back for part 3 of our coverage of some of the research from NAEMSP2020 in San Diego. If you missed parts 1 or 2, be sure to download them and listen. They were great! In this episode, we have two great interviews. We talk with Dr. Veer Vithalani of MedStar in Fort Worth, TX, about his work using EtCO2 to detect unrecognized BVM ventilation failures. We also chat with Drs. Casey Patrick and Rob Dickson from Montgomery County Hospital District EMS in Conroe, TX, about push-dose drugs, including epinephrine and nitroglycerin.

What if we told you that neither amiodarone nor lidocaine did any better in cardiac arrest when given by IO? What if we told you neither one improved survival when given by IV? Would you think I was smoking crack? Yeah, I would have thought that, too, until last week. I will quickly recap this important secondary analysis of the ALPS trial. As always, please subscribe and give us a 5-star rating on Apple Podcasts. We’d love to hear your thoughts, questions, and suggestions. Join us on Twitter: @DrJeffJarvis, @EMSLighthouse, @FlightBridgeED

And we’re back for part 2 of our coverage of some of the research from NAEMSP2020 in San Diego. If you missed part 1, be sure to download it and listen. It was great! As always, we want to hear your feedback. Let us know what you think: @DrJeffJarvis and @EMSLightouse. Subscribe and give us an excellent rating on Apple Podcast.